Determinants of Monocyte Apoptosis in Cardiorenal Syndrome Type 1

Background: Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is complex and not completely understood. In this study, we examined the role of apoptosis and the caspase pathways involved. Mater...

Full description

Saved in:
Bibliographic Details
Published in:Cardiorenal medicine Vol. 8; no. 3; pp. 208 - 216
Main Authors: Breglia, Andrea, Virzì, Grazia Maria, Pastori, Silvia, Brocca, Alessandra, de Cal, Massimo, Bolin, Chiara, Vescovo, Giorgio, Ronco, Claudio
Format: Journal Article
Language:English
Published: Basel, Switzerland S. Karger AG 01-01-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background: Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is complex and not completely understood. In this study, we examined the role of apoptosis and the caspase pathways involved. Material and Methods: We enrolled 40 acute heart failure (AHF) patients, 11 of whom developed AKI characterizing CRS type 1. We exposed the human cell line U937 to plasma from the CRS type 1 and AHF groups and then we evaluated apoptotic activity by annexin-V evaluation, determination of caspase-3, -8 and -9 levels, and BAX, BAD, and FAS gene expression. Results: We observed significant upregulation of apoptosis in monocytes exposed to CRS type 1 plasma compared to AHF, with increased levels of caspase-3 (p < 0.01), caspase-9 (p < 0.01), and caspase-8 (p < 0.03) showing activation of both intrinsic and extrinsic pathways. Furthermore, monocytes exposed to CRS type 1 plasma had increased gene expression of BAX and BAD (intrinsic pathways) (p = 0.010 for both). Furthermore, strong significant correlations between the caspase-9 levels and BAD and BAX gene expression were observed (Spearman ρ = – 0.76, p = 0.011, and ρ = – 0.72, p = 0.011). Conclusion: CRS type 1 induces dual apoptotic pathway activation in monocytes; the two pathways converged on caspase-3. Many factors may induce activation of both intrinsic and extrinsic apoptotic pathways in CRS type 1 patients, such as upregulation of proinflammatory cytokines and hypoxia/ischemia. Further investigations are necessary to corroborate the present findings, and to better understand the pathophysiological mechanism and consequent therapeutic and prognostic implications for CRS type 1.
AbstractList Background: Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is complex and not completely understood. In this study, we examined the role of apoptosis and the caspase pathways involved. Material and Methods: We enrolled 40 acute heart failure (AHF) patients, 11 of whom developed AKI characterizing CRS type 1. We exposed the human cell line U937 to plasma from the CRS type 1 and AHF groups and then we evaluated apoptotic activity by annexin-V evaluation, determination of caspase-3, -8 and -9 levels, and BAX, BAD, and FAS gene expression. Results: We observed significant upregulation of apoptosis in monocytes exposed to CRS type 1 plasma compared to AHF, with increased levels of caspase-3 (p < 0.01), caspase-9 (p < 0.01), and caspase-8 (p < 0.03) showing activation of both intrinsic and extrinsic pathways. Furthermore, monocytes exposed to CRS type 1 plasma had increased gene expression of BAX and BAD (intrinsic pathways) (p = 0.010 for both). Furthermore, strong significant correlations between the caspase-9 levels and BAD and BAX gene expression were observed (Spearman ρ = – 0.76, p = 0.011, and ρ = – 0.72, p = 0.011). Conclusion: CRS type 1 induces dual apoptotic pathway activation in monocytes; the two pathways converged on caspase-3. Many factors may induce activation of both intrinsic and extrinsic apoptotic pathways in CRS type 1 patients, such as upregulation of proinflammatory cytokines and hypoxia/ischemia. Further investigations are necessary to corroborate the present findings, and to better understand the pathophysiological mechanism and consequent therapeutic and prognostic implications for CRS type 1.
BACKGROUNDCardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is complex and not completely understood. In this study, we examined the role of apoptosis and the caspase pathways involved.MATERIAL AND METHODSWe enrolled 40 acute heart failure (AHF) patients, 11 of whom developed AKI characterizing CRS type 1. We exposed the human cell line U937 to plasma from the CRS type 1 and AHF groups and then we evaluated apoptotic activity by annexin-V evaluation, determination of caspase-3, -8 and -9 levels, and BAX, BAD, and FAS gene expression.RESULTSWe observed significant upregulation of apoptosis in monocytes exposed to CRS type 1 plasma compared to AHF, with increased levels of caspase-3 (p < 0.01), caspase-9 (p < 0.01), and caspase-8 (p < 0.03) showing activation of both intrinsic and extrinsic pathways. Furthermore, monocytes exposed to CRS type 1 plasma had increased gene expression of BAX and BAD (intrinsic pathways) (p = 0.010 for both). Furthermore, strong significant correlations between the caspase-9 levels and BAD and BAX gene expression were observed (Spearman ρ = - 0.76, p = 0.011, and ρ = - 0.72, p = 0.011).CONCLUSIONCRS type 1 induces dual apoptotic pathway activation in monocytes; the two pathways converged on caspase-3. Many factors may induce activation of both intrinsic and extrinsic apoptotic pathways in CRS type 1 patients, such as upregulation of proinflammatory cytokines and hypoxia/ischemia. Further investigations are necessary to corroborate the present findings, and to better understand the pathophysiological mechanism and consequent therapeutic and prognostic implications for CRS type 1.
Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is complex and not completely understood. In this study, we examined the role of apoptosis and the caspase pathways involved. We enrolled 40 acute heart failure (AHF) patients, 11 of whom developed AKI characterizing CRS type 1. We exposed the human cell line U937 to plasma from the CRS type 1 and AHF groups and then we evaluated apoptotic activity by annexin-V evaluation, determination of caspase-3, -8 and -9 levels, and BAX, BAD, and FAS gene expression. We observed significant upregulation of apoptosis in monocytes exposed to CRS type 1 plasma compared to AHF, with increased levels of caspase-3 (p < 0.01), caspase-9 (p < 0.01), and caspase-8 (p < 0.03) showing activation of both intrinsic and extrinsic pathways. Furthermore, monocytes exposed to CRS type 1 plasma had increased gene expression of BAX and BAD (intrinsic pathways) (p = 0.010 for both). Furthermore, strong significant correlations between the caspase-9 levels and BAD and BAX gene expression were observed (Spearman ρ = - 0.76, p = 0.011, and ρ = - 0.72, p = 0.011). CRS type 1 induces dual apoptotic pathway activation in monocytes; the two pathways converged on caspase-3. Many factors may induce activation of both intrinsic and extrinsic apoptotic pathways in CRS type 1 patients, such as upregulation of proinflammatory cytokines and hypoxia/ischemia. Further investigations are necessary to corroborate the present findings, and to better understand the pathophysiological mechanism and consequent therapeutic and prognostic implications for CRS type 1.
Author Virzì, Grazia Maria
de Cal, Massimo
Breglia, Andrea
Brocca, Alessandra
Vescovo, Giorgio
Ronco, Claudio
Pastori, Silvia
Bolin, Chiara
AuthorAffiliation a Department of Nephrology, Dialysis and Transplant, San Bortolo Hospital, Vicenza, Italy
c Department of Internal Medicine, University of Trieste, Trieste, Italy
f Internal Medicine Unit, Sant'Antonio Hospital, Padua, Italy
e Internal Medicine, San Bortolo Hospital, Vicenza, Italy
b IRRIV – International Renal Research Institute Vicenza, Vicenza, Italy
d Department of Medicine DIMED, University of Padua Medical School, Padua, Italy
AuthorAffiliation_xml – name: b IRRIV – International Renal Research Institute Vicenza, Vicenza, Italy
– name: a Department of Nephrology, Dialysis and Transplant, San Bortolo Hospital, Vicenza, Italy
– name: f Internal Medicine Unit, Sant'Antonio Hospital, Padua, Italy
– name: d Department of Medicine DIMED, University of Padua Medical School, Padua, Italy
– name: e Internal Medicine, San Bortolo Hospital, Vicenza, Italy
– name: c Department of Internal Medicine, University of Trieste, Trieste, Italy
Author_xml – sequence: 1
  givenname: Andrea
  surname: Breglia
  fullname: Breglia, Andrea
– sequence: 2
  givenname: Grazia Maria
  surname: Virzì
  fullname: Virzì, Grazia Maria
  email: graziamaria.virzi@gmail.com
– sequence: 3
  givenname: Silvia
  surname: Pastori
  fullname: Pastori, Silvia
– sequence: 4
  givenname: Alessandra
  surname: Brocca
  fullname: Brocca, Alessandra
– sequence: 5
  givenname: Massimo
  surname: de Cal
  fullname: de Cal, Massimo
– sequence: 6
  givenname: Chiara
  surname: Bolin
  fullname: Bolin, Chiara
– sequence: 7
  givenname: Giorgio
  surname: Vescovo
  fullname: Vescovo, Giorgio
– sequence: 8
  givenname: Claudio
  surname: Ronco
  fullname: Ronco, Claudio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29847820$$D View this record in MEDLINE/PubMed
BookMark eNptkN1LwzAUxYNMnM49-C5S8EUfpkmapumLMOonbAi695A2yay2SU06of-9HZ1Fwad74fzuOZdzBEbGGgXACYJXCEXJNYSQMJaQZA8cIkrJLIogHu32kGE2BlPv3zsMRhQlMDoAY5wwEjMMD8H8VjXKVYURpvGB1cHSGpu3jQrmta0b6wsfFCZIhZOFdcqIMnhtjXS2UsGqrVWAjsG-FqVX092cgNX93Sp9nC2eH57S-WKWE0yaWUyl1CIXXayQimkcJVLrTIsY4RhJTHKJMIGUZBKHBEoSaYoE04JBkkUsnICb3rbeZJWSuTKNEyWvXVEJ13IrCv5XMcUbX9svTlEME0g7g4udgbOfG-UbXhU-V2UpjLIbzzEkcYJpTLdZlz2aO-u9U3qIQZBvS-dD6R179vuvgfypuANOe-BDuLVyAzDcn_8rpy_LnuC11OE3_yyT0g
CitedBy_id crossref_primary_10_1016_S0140_6736_19_32563_2
crossref_primary_10_3390_cells10071824
crossref_primary_10_1007_s40620_019_00613_2
crossref_primary_10_2174_1570161118666200628024027
crossref_primary_10_1007_s10529_018_2614_4
crossref_primary_10_1097_EC9_0000000000000049
crossref_primary_10_1159_000497748
Cites_doi 10.1038/nrneph.2011.16
10.1073/pnas.0406421101
10.1159/000371898
10.1016/j.cellsig.2003.08.007
10.1159/000438459
10.1159/000444502
10.1016/S0002-9440(10)63747-9
10.1159/000349969
10.1159/000362650
10.1007/s40620-017-0425-7
10.1016/j.jacc.2008.07.051
10.1002/ijc.2910170504
10.1016/j.molcel.2010.09.022
10.1159/000122110
10.1038/onc.2009.44
10.2174/1568008054863754
10.1007/s10741-016-9534-y
10.1186/cc5713
10.1016/j.molcel.2010.01.025
10.1093/eurheartj/ehp507
10.1155/2015/391790
10.1038/ki.2009.224
10.1159/000452283
10.1016/S0955-0674(99)80034-9
10.1038/bjc.1972.33
10.1016/0092-8674(95)90071-3
10.1159/000443008
10.1681/ASN.2007121336
10.1159/000089452
10.1159/000438831
10.1038/ki.2011.120
ContentType Journal Article
Copyright 2018 S. Karger AG, Basel
2018 S. Karger AG, Basel.
Copyright © 2018 by S. Karger AG, Basel 2018
Copyright_xml – notice: 2018 S. Karger AG, Basel
– notice: 2018 S. Karger AG, Basel.
– notice: Copyright © 2018 by S. Karger AG, Basel 2018
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1159/000488949
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1664-5502
EndPage 216
ExternalDocumentID 10_1159_000488949
29847820
488949
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0~5
0~B
3O.
4.4
53G
8UI
AAKDD
AAYIC
ABDBF
ABJNI
ABPAZ
ACGFS
ACPSR
ADBBV
AENEX
AEYAO
AFJJK
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZPMC
BAWUL
CYUIP
DIK
E0A
EBS
EJD
EX3
FB.
HYE
HZ~
IY7
KUZGX
M--
N9A
O1H
O9-
OK1
OVD
RKO
RPM
TEORI
UJ6
WOW
3V.
7RV
7X7
8AO
8FI
8FJ
ABUWG
AFKRA
BENPR
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CUY
CVF
ECM
EIF
FYUFA
GROUPED_DOAJ
HMCUK
IAO
IHR
INH
ITC
NAPCQ
NPM
PQQKQ
PROAC
UKHRP
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c424t-76ddfaca782ade8f259dffbfa71271d24cd124064bd2340d45f61a8fa804b583
IEDL.DBID RPM
ISSN 1664-3828
IngestDate Tue Sep 17 21:03:16 EDT 2024
Sun Sep 29 07:46:13 EDT 2024
Thu Nov 21 20:24:36 EST 2024
Wed Oct 16 00:50:40 EDT 2024
Thu Aug 29 12:04:32 EDT 2024
Thu Sep 05 17:57:47 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Caspase
Cardiorenal syndrome
Monocytes
Apoptosis
Language English
License Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
2018 S. Karger AG, Basel.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c424t-76ddfaca782ade8f259dffbfa71271d24cd124064bd2340d45f61a8fa804b583
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Andrea Breglia and Grazia Maria Virzì contributed equally to this work.
ORCID 0000-0002-6697-4065
OpenAccessLink https://www.karger.com/Article/Pdf/488949
PMID 29847820
PQID 2047926768
PQPubID 23479
PageCount 9
ParticipantIDs karger_primary_488949
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6170906
crossref_primary_10_1159_000488949
pubmed_primary_29847820
proquest_miscellaneous_2047926768
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
– name: Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH-4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch
PublicationTitle Cardiorenal medicine
PublicationTitleAlternate Cardiorenal Med
PublicationYear 2018
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References Virzì GM, de Cal M, Day S, Brocca A, Cruz DN, Castellani C, et al: Pro-apoptotic effects of plasma from patients with cardiorenal syndrome on human tubular cells. Am J Nephrol 2015; 41: 474–484.2622878910.1159/000438459
Virzì GM, Clementi A, Brocca A, de Cal M, Ronco C: Molecular and genetic mechanisms involved in the pathogenesis of cardiorenal cross talk. Pathobiology 2016; 83: 201–210.2709674710.1159/000444502
Virzì GM, Torregrossa R, Cruz DN, Chionh CY, de Cal M, Soni SS, et al: Cardiorenal syndrome type 1 may be immunologically mediated: a pilot evaluation of monocyte apoptosis. Cardiorenal Med 2012; 2: 33–42.22493601
Bordoni V, Piroddi M, Galli F, de Cal M, Bonello M, Dimitri P, et al: Oxidant and carbonyl stress-related apoptosis in end-stage kidney disease: impact of membrane flux. Blood Purif 2006; 24: 149–156.1636185610.1159/000089452
Michiels C: Physiological and pathological responses to hypoxia. Am J Pathol 2004; 164: 1875–1882.1516162310.1016/S0002-9440(10)63747-9
de Cal M, Cruz DN, Corradi V, Nalesso F, Polanco N, Lentini P, et al: HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients. Blood Purif 2008; 26: 249–254.1837610610.1159/000122110
Wang Y, Fang Y, Teng J, Ding X: Acute kidney injury epidemiology: from recognition to intervention. Contrib Nephrol 2016; 187: 1–8.2688180210.1159/000443008
Pastori S, Virzì GM, Brocca A, de Cal M, Clementi A, Vescovo G, et al: Cardiorenal syndrome type 1: a defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors. Cardiorenal Med 2015; 5: 105–115.2599995910.1159/000371898
Faubel S, Edelstein CL: Caspases as drug targets in ischemic organ injury. Curr Drug Targets Immune Endocr Metabol Disord 2005; 5: 269–287.1617878810.2174/1568008054863754
Majmundar AJ, Wong WJ, Simon MC: Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 2010; 40: 294–309.2096542310.1016/j.molcel.2010.09.022
Haase M, Muller C, Damman K, Murray PT, Kellum JA, Ronco C, et al: Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182: 99–116.2368965810.1159/000349969
Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al: Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 2010; 31: 703–711.2003714610.1093/eurheartj/ehp507
Virzì GM, Clementi A, de Cal M, Brocca A, Day S, Pastori S, et al: Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis. Oxid Med Cell Longev 2015; 2015: 391790.2582155410.1155/2015/391790
Thorburn A: Death receptor-induced cell killing. Cell Signal 2004; 16: 139–144.1463688410.1016/j.cellsig.2003.08.007
Sanz AB, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A: Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol 2008; 19: 1634–1642.1863284610.1681/ASN.2007121336
Hamar P, Song E, Kokeny G, Chen A, Ouyang N, Lieberman J: Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci USA 2004; 101: 14883–14888.1546670910.1073/pnas.0406421101
Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527–1539.1900758810.1016/j.jacc.2008.07.051
Virzì GM, Clementi A, Ronco C: Cellular apoptosis in the cardiorenal axis. Heart Fail Rev 2016; 21: 177–189.2685214110.1007/s10741-016-9534-y
Price PM, Safirstein RL, Megyesi J: The cell cycle and acute kidney injury. Kidney Int 2009; 76: 604–613.1953608010.1038/ki.2009.224
Havasi A, Borkan SC: Apoptosis and acute kidney injury. Kidney Int 2011; 80: 29–40.2156246910.1038/ki.2011.120
Sharfuddin AA, Molitoris BA: Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 2011; 7: 189–200.2136451810.1038/nrneph.2011.16
Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR: The BCL-2 family reunion. Mol Cell 2010; 37: 299–310.2015955010.1016/j.molcel.2010.01.025
Virzì GM, Clementi A, Brocca A, de Cal M, Vescovo G, Granata A, et al: The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1. Cardiorenal Med 2014; 4: 103–112.2525403210.1159/000362650
Zhang J, Bottiglieri T, McCullough PA: The central role of endothelial dysfunction in cardiorenal syndrome. Cardiorenal Med 2017; 7: 104–117.2861178410.1159/000452283
Ashkenazi A, Dixit VM: Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 11: 255–260.1020915310.1016/S0955-0674(99)80034-9
Danial NN: BAD: undertaker by night, candyman by day. Oncogene 2008; 27(suppl 1):S53–S70.1964150710.1038/onc.2009.44
Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–257.456102710.1038/bjc.1972.33
Chinnaiyan AM, O’Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505–512.753890710.1016/0092-8674(95)90071-3
Pastori S, Virzì GM, Brocca A, de Cal M, Cantaluppi V, Castellani C, et al: Cardiorenal syndrome type 1: activation of dual apoptotic pathways. Cardiorenal Med 2015; 5: 306–315.2664894710.1159/000438831
Virzì GM, Clementi A, Brocca A, de Cal M, Ronco C: Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes. J Nephrol 2017, DOI: 10.1007/s40620-017-0425-7.2878071610.1007/s40620-017-0425-7
Sundstrom C, Nilsson K: Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976; 17: 565–577.17861110.1002/ijc.2910170504
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.1733124510.1186/cc5713
ref13
ref12
ref15
ref14
ref31
ref30
ref11
ref10
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref19
  doi: 10.1038/nrneph.2011.16
– ident: ref31
  doi: 10.1073/pnas.0406421101
– ident: ref7
  doi: 10.1159/000371898
– ident: ref25
  doi: 10.1016/j.cellsig.2003.08.007
– ident: ref5
  doi: 10.1159/000438459
– ident: ref11
  doi: 10.1159/000444502
– ident: ref22
  doi: 10.1016/S0002-9440(10)63747-9
– ident: ref3
  doi: 10.1159/000349969
– ident: ref8
  doi: 10.1159/000362650
– ident: ref12
  doi: 10.1007/s40620-017-0425-7
– ident: ref1
  doi: 10.1016/j.jacc.2008.07.051
– ident: ref16
  doi: 10.1002/ijc.2910170504
– ident: ref21
  doi: 10.1016/j.molcel.2010.09.022
– ident: ref14
  doi: 10.1159/000122110
– ident: ref26
  doi: 10.1038/onc.2009.44
– ident: ref30
  doi: 10.2174/1568008054863754
– ident: ref9
  doi: 10.1007/s10741-016-9534-y
– ident: ref15
  doi: 10.1186/cc5713
– ident: ref27
  doi: 10.1016/j.molcel.2010.01.025
– ident: ref2
  doi: 10.1093/eurheartj/ehp507
– ident: ref6
  doi: 10.1155/2015/391790
– ident: ref20
  doi: 10.1038/ki.2009.224
– ident: ref10
  doi: 10.1159/000452283
– ident: ref24
  doi: 10.1016/S0955-0674(99)80034-9
– ident: ref18
  doi: 10.1038/bjc.1972.33
– ident: ref23
  doi: 10.1016/0092-8674(95)90071-3
– ident: ref4
  doi: 10.1159/000443008
– ident: ref29
  doi: 10.1681/ASN.2007121336
– ident: ref13
  doi: 10.1159/000089452
– ident: ref28
  doi: 10.1159/000438831
– ident: ref17
  doi: 10.1038/ki.2011.120
SSID ssj0000561905
Score 2.1616454
Snippet Background: Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its...
Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its pathophysiology is...
BACKGROUNDCardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Its...
SourceID pubmedcentral
proquest
crossref
pubmed
karger
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 208
SubjectTerms Aged
Aged, 80 and over
Apoptosis
bcl-2-Associated X Protein - genetics
bcl-Associated Death Protein - genetics
Cardio-Renal Syndrome - blood
Cardio-Renal Syndrome - enzymology
Cardio-Renal Syndrome - pathology
Caspase 3 - blood
Caspase 8 - blood
Caspase 9 - blood
Caspases - blood
Enzyme Activation
Fas Ligand Protein - genetics
Female
Gene Expression
Heart Failure - blood
Heart Failure - pathology
Humans
Male
Middle Aged
Monocytes - pathology
Original Paper
U937 Cells
Title Determinants of Monocyte Apoptosis in Cardiorenal Syndrome Type 1
URI https://karger.com/doi/10.1159/000488949
https://www.ncbi.nlm.nih.gov/pubmed/29847820
https://search.proquest.com/docview/2047926768
https://pubmed.ncbi.nlm.nih.gov/PMC6170906
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED7RioEFgSgQKMgg1rR5OIkzVi0VCwhRBrbI8dmiApKoj4F_j-0kVamYWP2Sc77k7nM-fwa4wzAMVWx5YZ5waeQzl0vmuTT0ZJrrmBuj2e94mCVPb2xyb2RyovYsjCXti3w-KD6_BsX83XIrqy8xbHliw-fHsRERT7142IGOzg23IHot6K0xgaUu-nFM3VBDikZRSEfuoT1EzVJq1EKDVH-ambnpeysk7X8YBvbir4Rzlze5FYimR3DYZJBkVM_0GPZkcQKjyRathZSK6He1FN8rSUZVWa3K5XxJ5gUZW_bpQpoBZo1WATFQlPg9eJ3ev44f3OZ2BFfQgK7cJEZUXHD9BBwlUxrHoFK54okfJD4GVKBvwjXNMQiphzRSsc-Z4syjecTCU-gWZSHPgWjEEWCKnop0L0YlQy_hAnVy4ieJwNyB29Y-WVVrYGQWO0RptrGnA73acpsmbXl_p3z88lhXZRUqB25aO2fasc3fCl7Icr3MAiN-H8R6cg6c1XbfDNGunAPJrxXZNDCi2b9rtC9Z8ezGdy7-3fMSDnTSxOptmD50V4u1vILOEtfX1hF_AEsp4PM
link.rule.ids 230,315,729,782,786,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xqAQXoCqPwJa6Va9hncRJnONqWbRVWVSVPfQWOR5bXZVNon0c-PfYTrJaUE9c_VLsL5OZcT5_BviOURTpxPHCqPRZHHBfKE59FlGVFcbnJmj3O8aP6cMffjuyMjlxdxbGkfZlMbspn-Y35eyv41bWc9nveGL9X5OhFRHPaNLfhX1jr5RuJemNpLfJChx5MUgS5kcmqWg1hYzv7rtj1DxjVi80zMzHmdu7vrec0od_loO9-F_I-ZY5ueWK7o7fOYkTOGpjTzJoqj_Cjio_weB2ixBDKk2MlVfyeaXIoK7qVbWcLcmsJEPHW10oO8Bjq3JAbBJLglOY3o2mw7Hf3qvgSxaylZ8miFpIYWYuUHFtMiDUutAiDcI0wJBJDKyjZwWGEaPIYp0EgmvBKStiHp3BXlmV6gKIyVVCzJDq2PTiTHGkqZBowpogTSUWHnzr1jWvG_WM3GUdcZZvcPDgtFnxTZOuvPemfPh70lTlNWoPvnb45MYk7H8OUapqvcxDK5sfJubhPDhv8NoM0SHuQfoKyU0DK7f9usYA6GS3W8Au393zCxyMp5P7_P7Hw88rODShF282c3qwt1qs1WfYXeL62r3ML5XX9ng
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtQwFL3qAyE2UESBQAEXsU3jOE7iLEczHbWCVlXbBbvI8UOMoEk0jwV_z7Xz0LTqim79UuIT597jnBwDfNNJktjM68KoCnkai1AaQUOeUFNUGHMz7fY7zm7yy59idupscsajvrxoX1WLk_rP3Um9-OW1le2digadWHR1MXUm4gXNolbbaBf2cc1StkXUO1tvZAZewBhnGQ8TJBa9rxDG78j_Si0K7jxDWYEvaOHO-94KTM9-Ox328rG086F6cisczV894UYO4GWfg5JJ1-Q17Jj6DUxmW8IY0liCq71Rf9eGTNqmXTerxYosajL1-tWlcQPc9G4HxJFZEh_C7fz0dnoW9ucrhIozvg7zTGsrlcS7l9oIi0xIW1tZmccsjzXjSscu4PNKs4RTzVObxVJYKSivUpG8hb26qc17IMhZmC40tSn2EtwITXOpNKY3cZ4rXQXwdZjbsu1cNErPPtKiHLEI4LCb9bHJUH70oHx6fdFVlThxARwPGJW4NNz3DlmbZrMqmbPPZxleXADvOszGIQbUA8jvoTk2cLbb92sQRG-_3YP24b97foHnV7N5-eP88vtHeIEZmOj2dI5gb73cmE-wu9Kbz_55_gdq4Pj4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determinants+of+Monocyte+Apoptosis+in+Cardiorenal+Syndrome+Type+1&rft.jtitle=Cardiorenal+medicine&rft.au=Breglia%2C+Andrea&rft.au=Virz%C3%AC%2C+Grazia+Maria&rft.au=Pastori%2C+Silvia&rft.au=Brocca%2C+Alessandra&rft.date=2018-01-01&rft.eissn=1664-5502&rft.volume=8&rft.issue=3&rft.spage=208&rft.epage=216&rft_id=info:doi/10.1159%2F000488949&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3828&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3828&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3828&client=summon